In AML-exposed CAR T cells, C-JUN did promote IL-2 expression at the RNA and protein levels, whereas IFN-γ was only upregulated at the protein level, suggesting that C-JUN may promote anti-tumor efficacy at least partly by increasing these cytokines. The gene discussed is JUN; the disease is acute myeloid leukemia.